Company
Gatlan
Gatlan publishes unspecified GLP-1 at $125 a month — Medical Weight Loss, starting price.
- 1 program
- 1 molecule
- 1 reading
Read from gatlan.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Gatlan
We earn nothing from this link. Gatlan has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Medical Weight Loss, starting price
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. /pricing, /weight-loss, and /semaglutide all redirect to the homepage; real content is at /mens-health-products/, /womens-health-products/, and /health-optimization-products/ (identical content on all three). Neither semaglutide nor tirzepatide is named anywhere — the site only says 'GLP-1 and GLP-1/GIP medications' and 'advanced incretin mimetics', and explicitly states 'Gatlan does not offer Retatrutide or any unapproved triple-receptor agonist treatments. Our weight management programs strictly utilize FDA-approved single and dual-agonist therapies' — this phrase suggests brand medication but no brand name (Wegovy/Ozempic/Zepbound/Mounjaro) is ever printed, so drug is recorded as unspecified GLP-1 rather than assumed. No page stating served states was found (checked homepage, all three product pages, and terms). No cancellation-specific page exists; the only relevant text is a discretionary, non-guaranteed refund clause in the Terms of Service.
Before you act
Cite this
Treatment Registry. (2026). Gatlan: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/gatlan